Kusajili – Centralise les essais cliniques mondiaux

Résultat de votre recherche par promoteur : Pfizer Inc. 235 East 42nd Street NY10017

Femme et Homme Max 99 ans
Pfizer Inc. 235 East 42nd Street NY10017 MAJ Il y a 4 ans

A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF CE-224,535, AN ANTAGONIST OF THE P2X7 RECEPTOR, IN THE TREATMENT OF THE SIGNS AND SYMPTOMS OF RHEUMATOID ARTHRITIS IN SUBJECTS WHO ARE INADEQUATELY CONTROLLED ON METHOTREXATE The primary objective of this study is to test the efficacy of CE-224,535 vs placebo as assessed by the American College of Rheumatology 20 (ACR 20) Response Rate at 12 weeks in RA subjects inadequate...

Pays Aucun
Organes Aucun
Spécialités Aucune

unknown

Plus d'informations